PCN233 COST EFFECTIVENESS OF OBINUTUZUMAB PLUS BENDAMUSTINE VS BENDAMUSTINE ALONE FOR PATIENTS WHO DID NOT RESPOND OR PROGRESSED DURING OR AFTER RITUXIMAB OR A RITUXIMAB CONTAINING REGIMENT IN TURKEY
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.428
https://www.valueinhealthjournal.com/article/S1098-3015(19)32806-2/fulltext
Section Title :
Section Order :
10355
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32806-2&doi=10.1016/j.jval.2019.09.428